PEB Pacific Edge's APAC operations advancing towards profit with cancer test growth Pacific Edge APAC business is advancing towards profitability on a direct-cost basis with a growing interest in its testing services. Colin Sandell-Hay 15 hours ago ASX News Healthcare Biotechnology
NOX Noxopharm welcomes award of childbirth MRFF grant for Sofra platform Noxopharm has welcomed the awarding of a $1 million medical research future fund grant for a project involving the company’s Sofra platform. Colin Sandell-Hay 02 Jul 2026 12:37 (AEST) ASX News Healthcare Steel Biotechnology Basic Materials
1AI Algorae secures NSW Health hospital supply agreement through AlgoraeRx Algorae Pharmaceuticals has secured a NSW Health standing offer arrangement through its AlgoraeRx division. Seja Al Zaidi 02 Jul 2026 11:49 (AEST) ASX News Healthcare Biotechnology
MEM Memphasys secures exclusive $430K Thailand distribution deal for Felix sperm system Memphasys (ASX:MEM) has signed a three-year Thailand distribution deal with IVF Envimed for its Felix sperm separation system. The exclusive contract guarantees A$430,500 over its three-year term, boosting the company’s South-East Asian revenue to A$1 million and driving total FY2... Isaac McIntyre 01 Jul 2026 10:21 (AEST) ASX News Healthcare Biotechnology
NEU Neuren Pharmaceuticals welcomes milestone approval for Daybu Neuren Pharmaceuticals has received positive news for the proposed marketing of the Daybu treatment of Rett syndrome. Colin Sandell-Hay 29 Jun 2026 09:53 (AEST) ASX News Healthcare Biotechnology
MEM Memphasys secures UK market entry, accelerating commercial rollout Memphasys has entered the U.K. fertility market with four IVF groups putting in commercial orders to trial its Felix system. Seja Al Zaidi 25 Jun 2026 11:52 (AEST) ASX News Healthcare Biotechnology
PAR Paradigm Biopharma completes enrolment in pivotal Phase 3 osteoarthritis trial Welcome to HotCopper’s latest Watchlist, where we’ve this week been joined by Paradigm Biopharmaceuticals (ASX:PAR) managing director Paul Rennie to talk about what’s next after the company just cracked another @major milestone&CloseCurlyDoubleQuote... Isaac McIntyre 16 Jun 2026 14:10 (AEST) ASX News The Watchlist Healthcare Biotechnology
MEM Memphasys lands national Monash IVF supply deal for Felix system Memphasys has secured a 12-month exclusive national supply agreement with Monash IVF for its Felix sperm selection system. Seja Al Zaidi 16 Jun 2026 11:45 (AEST) ASX News Healthcare Biotechnology
PAR Paradigm clears key Phase 3 hurdle as osteoarthritis trial enrolment completes Paradigm Biopharmaceuticals has completed enrolment in its pivotal Phase 3 osteoarthritis trial, with top-line results due in early 2027. Seja Al Zaidi 15 Jun 2026 12:02 (AEST) ASX News Healthcare Biotechnology
MEM Memphasys inks maiden South-East Asian commercialisation agreement Memphasys has signed an exclusive agreement with TMSC Vietnam for the sale and distribution of its unique Felix System. Colin Sandell-Hay 01 Jun 2026 12:40 (AEST) ASX News Healthcare Biotechnology
MEM Memphasys receives order for 1000 Felix cartridges across MENA markets Memphasys continues to expand the global market for its Felix system with new orders from the Middle East and North Africa (MENA) region. Colin Sandell-Hay 27 May 2026 11:22 (AEST) ASX News Healthcare Biotechnology
NOX Noxopharm leaps on confirmation of cancer-fighting potential with new Sofra data Noxopharm has obtained new data showing how the Sofra technology platform will be leveraged to fight cancer. Colin Sandell-Hay 26 May 2026 14:26 (AEST) ASX News Healthcare Biotechnology
ILA Island Pharmaceuticals makes key appointment ahead of US biodefence trials Island Pharmaceuticals has made a key appointment ahead of US biodefence trials and dose optimisation studies. Colin Sandell-Hay 19 May 2026 16:23 (AEST) ASX News Healthcare Biotechnology
